Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.

Struck W, Siluk D, Yumba-Mpanga A, Markuszewski M, Kaliszan R, Markuszewski MJ.

J Chromatogr A. 2013 Mar 29;1283:122-31. doi: 10.1016/j.chroma.2013.01.111. Epub 2013 Feb 6.

PMID:
23465127
2.

Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.

Struck-Lewicka W, Kaliszan R, Markuszewski MJ.

J Pharm Biomed Anal. 2014 Dec;101:50-7. doi: 10.1016/j.jpba.2014.04.022. Epub 2014 May 1. Review.

PMID:
24840632
3.

Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.

Hsu WY, Chen WT, Lin WD, Tsai FJ, Tsai Y, Lin CT, Lo WY, Jeng LB, Lai CC.

Clin Chim Acta. 2009 Apr;402(1-2):31-7. doi: 10.1016/j.cca.2008.12.009. Epub 2008 Dec 16.

PMID:
19135043
4.

[Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].

Feng B, Zheng MH, Zheng YF, Lu AG, Li JW, Wang ML, Ma JJ, Xu GW, Yu BM.

Zhonghua Wai Ke Za Zhi. 2005 May 1;43(9):564-8. Chinese.

PMID:
15938925
5.
6.

Development and validation of a hydrophilic interaction chromatography-tandem mass spectrometry method with on-line polar extraction for the analysis of urinary nucleosides. Potential application in clinical diagnosis.

Rodríguez-Gonzalo E, García-Gómez D, Carabias-Martínez R.

J Chromatogr A. 2011 Dec 16;1218(50):9055-63. doi: 10.1016/j.chroma.2011.10.016. Epub 2011 Oct 12.

PMID:
22056237
7.

Analysis of urinary methylated nucleosides of patients with coronary artery disease by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.

Li Y, Yu H, Zhao W, Xu X, Zhou J, Xu M, Gao W, Yuan G.

Rapid Commun Mass Spectrom. 2014 Oct 15;28(19):2054-8. doi: 10.1002/rcm.6986.

PMID:
25156594
8.

Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.

Seidel A, Brunner S, Seidel P, Fritz GI, Herbarth O.

Br J Cancer. 2006 Jun 5;94(11):1726-33.

9.

Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.

Hsu WY, Lin WD, Tsai Y, Lin CT, Wang HC, Jeng LB, Lee CC, Lin YC, Lai CC, Tsai FJ.

Clin Chim Acta. 2011 Sep 18;412(19-20):1861-6. doi: 10.1016/j.cca.2011.06.027. Epub 2011 Jun 30.

PMID:
21740897
10.

Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.

Yang J, Xu G, Kong H, Zheng Y, Pang T, Yang Q.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):27-33.

PMID:
12383477
11.

Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.

Rodríguez-Gonzalo E, Herrero-Herrero L, García-Gómez D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 15;1019:132-9. doi: 10.1016/j.jchromb.2015.10.044. Epub 2015 Nov 2.

PMID:
26565068
12.

Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.

Bullinger D, Fröhlich H, Klaus F, Neubauer H, Frickenschmidt A, Henneges C, Zell A, Laufer S, Gleiter CH, Liebich H, Kammerer B.

Anal Chim Acta. 2008 Jun 16;618(1):29-34. doi: 10.1016/j.aca.2008.04.048. Epub 2008 May 1.

PMID:
18501242
13.

Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.

Li HY, Wang SM, Liu HM, Bu SS, Li J, Han D, Zhang MZ, Wu GY.

J Mass Spectrom. 2009 May;44(5):641-51. doi: 10.1002/jms.1539.

PMID:
19142897
14.

Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.

Jeng LB, Lo WY, Hsu WY, Lin WD, Lin CT, Lai CC, Tsai FJ.

Rapid Commun Mass Spectrom. 2009 Jun;23(11):1543-9. doi: 10.1002/rcm.4034.

PMID:
19399767
15.

Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.

Feng B, Zheng MH, Zheng YF, Lu AG, Li JW, Wang ML, Ma JJ, Xu GW, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2005 Dec;20(12):1913-9.

PMID:
16336453
16.

Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.

Langridge JI, McClure TD, el-Shakawi S, Fielding A, Schram KH, Newton RP.

Rapid Commun Mass Spectrom. 1993 Jun;7(6):427-34.

PMID:
8329765
17.

Hydrophilic interaction ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry for determination of nucleotides, nucleosides and nucleobases in Ziziphus plants.

Guo S, Duan JA, Qian D, Wang H, Tang Y, Qian Y, Wu D, Su S, Shang E.

J Chromatogr A. 2013 Aug 2;1301:147-55. doi: 10.1016/j.chroma.2013.05.074. Epub 2013 Jun 6.

PMID:
23800804
18.

Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry.

Konieczna L, Bączek T, Belka M, Fel A, Markuszewski M, Struck W, Markuszewski M, Kaliszan R.

J Pharm Biomed Anal. 2013 Jan 25;73:108-15. doi: 10.1016/j.jpba.2012.03.016. Epub 2012 Mar 16.

PMID:
22475516
19.

Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma.

Djukovic D, Baniasadi HR, Kc R, Hammoud Z, Raftery D.

Rapid Commun Mass Spectrom. 2010 Oct 30;24(20):3057-62. doi: 10.1002/rcm.4739.

PMID:
20872639
20.

Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.

Waszczuk-Jankowska M, Markuszewski MJ, Markuszewski M, Kaliszan R.

Bioanalysis. 2012 Jun;4(10):1185-94. doi: 10.4155/bio.12.89.

PMID:
22651562

Supplemental Content

Support Center